Position in BSX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,963,698
+$988,077 QoQ
Shares Held
31,294
+205.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026GSA CAPITAL PARTNERS LLP holds $31,522,666 across 48 Medical Devices names. BSX ranks #3 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
44,579 | $4,576,925 | |
| 2 | PRCT |
PROCEPT BioRobotics Corp
|
78,677 | $1,967,711 | |
| 3 | BSX |
Boston Scientific Corp
This page
|
31,294 | $1,963,698 | |
| 4 | PODD |
Insulet Corp
|
7,878 | $1,653,119 | |
| 5 | NPCE |
NeuroPace Inc
|
117,672 | $1,547,386 | |
| 6 | MASS |
908 Devices Inc.
|
251,028 | $1,536,291 | |
| 7 | INFU |
InfuSystem Holdings, Inc
|
162,670 | $1,501,444 | |
| 8 | OFIX |
Orthofix Medical Inc.
|
121,226 | $1,390,462 |
All Filings in BSX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,963,698 | 31,294 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $975,621 | 10,232 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,858,387 | 19,035 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $359,608 | 3,348 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $416,432 | 4,128 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $294,666 | 3,299 | Shares | Sole | 2025-02-07 | |
| 2022-06-30 | $714,913 | 19,182 | Shares | Sole | 2022-08-09 | |
| 2020-09-30 | $287,759 | 7,531 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $269,469 | 7,675 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||